Accessibility Menu
Veri Medtech logo

Veri Medtech(OTC) LGMH

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)-66%
5 Year+56%
1 Year+484%
1 Month+20%
N/A
Veri Medtech last closing stock price
MetricPriceDate
Last closeUSD 2.352026-07-31
Veri Medtech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+17.32%USD 2.002026-07-23
1 month+20.05%USD 1.952026-06-23
3 month+139.43%USD 0.982026-04-17
Year to date+87.71%USD 1.252025-12-31
1 year+483.68%USD 0.402025-07-31
3 year+698.1%USD 0.292023-07-27
5 year+56.43%USD 1.502021-07-28
Since inception-66.48%USD 7.002010-10-22

Veri Medtech Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$134.16K

Net Income (TTM)

-$142.26K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

LGMH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veri Medtech

Veri Medtech Holdings Inc. is a healthcare technology company that provides health and wellness services through its innovative online platforms. The company focuses on bridging the gap between mental health professionals and clients, offering services under the Veriheal and DosePop brand names.

Products and Services
  • Online therapy platforms connecting clients with mental health professionals
  • Health and wellness services tailored to individual needs
  • Innovative healthcare technology solutions for improved patient outcomes
Growth Outlook
  • Revenue increased to $2.44 million in Q1 2026, up from $2.17 million in Q4 2025
  • Gross profit margin improved to 74.9% in Q1 2026, indicating operational efficiency
  • Strong demand for mental health services supports future growth potential
Financial Highlights
  • Trailing twelve months (TTM) revenue of $9.5 million, reflecting a growing market presence
  • Operating cash flow of $86,889 in Q1 2026, showcasing positive cash generation
  • Net income loss narrowed to $184,656 in Q1 2026, indicating improved financial performance
Veri Medtech Holdings Inc. operates in the healthcare sector, specifically focusing on mental health services. The company has shown promising growth in revenue and gross profit margins, which are critical indicators of operational efficiency. The recent quarterly results highlight a significant increase in revenue, suggesting a positive trend in demand for its services. The improvement in cash flow further supports the company's ability to sustain operations and invest in future growth. The healthcare technology landscape is evolving, and Veri Medtech is well-positioned to capitalize on the increasing need for mental health support. With a focus on innovative solutions and a commitment to enhancing patient outcomes, the company presents an intriguing opportunity for potential investors interested in the healthcare sector.
AI Generated • Jul 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Samuel Adetunji

Website

www.verimedtech.com

Headquarters

Atlanta, GA 30303, US

LGMH Financials

Key Financial Metrics (TTM)

Gross Margin

68.93%

Operating Margin

-22.01%

Net Income Margin

-22.50%

Return on Equity

87.53%

Return on Capital

-38.17%

Return on Assets

-1212.30%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$116.98K

Operating Income

-$31.30K

EBITDA

-$140.30K

Operating Cash Flow

-$139.85K

Capital Expenditure

$0.00

Free Cash Flow

-$139.85K

Cash & ST Invst.

$11.38K

Total Debt

$0.00

Veri Medtech Performance Analysis

Veri Medtech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 25,169-73.8%
20232023-12-31USD 78,125210.4%
20242024-12-31USD 16,653,26121216.2%
20252025-12-31USD 10,848,200-34.9%
Veri Medtech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30323.9%
Q42023-12-3179.7%
Q12024-03-31-9.7%
Q22024-06-30-24.0%
Veri Medtech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01-84.0%
20232023-12-31USD -0.0256.3%
20242024-12-31USD -0.0460.4%
20252025-12-31USD -0.12228.7%
Veri Medtech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30-33.3%
Q42023-12-31125.0%
Q12024-03-31-200.0%
Q22024-06-30-2100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$29.26K

+422.5%

Gross Profit

$24.09K

+442.8%

Gross Margin

82.33%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$121.52K

-582.8%

EBITDA

-$121.03K

-599.3%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$11.38K

-74.6%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-12.12%

N/A

Return on Invested Capital

84.05%

N/A

Free Cash Flow

-$120.56K

-60.1%

Operating Cash Flow

-$120.56K

-60.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHNDChina Media Inc.
$1.00+0.00%
CYPXFEQ Inc.
$0.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TTDThe Trade Desk
$17.67-0.07%
DVDoubleVerify
$11.71-0.02%
SPCXSpace Exploration Technologies
$114.92+0.06%
PCGPG&E
$17.00-0.01%

Questions About LGMH

What is the current price of Veri Medtech?

Veri Medtech is trading at N/A per share.

What is the 52-week range for Veri Medtech?

Over the past 52 weeks, Veri Medtech has traded between N/A and N/A.

How much debt does Veri Medtech have?

As of the most recent reporting period, Veri Medtech reported total debt of $422.14K.

How much cash does Veri Medtech have on hand?

Veri Medtech reported $6.15K in cash and cash equivalents in its most recent financial results.

What is Veri Medtech’s dividend yield?

Veri Medtech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services